Summary: Stress and relaxation are often talked about as if they were one thing, but research measures them in very different ways. A study may find a change in heart-rate variability without participants actually feeling more relaxed. Another may show lower blood pressure without showing any change in anxiety. Those differences matter.

The human PEMF literature reflects that split. Some controlled studies report changes in autonomic or cardiovascular markers, especially after physical stress or during repeated whole-body exposure. But studies of perceived stress, chronic anxiety, burnout, and subjective relaxation are much less consistent.

So the useful question is not simply, “Does PEMF reduce stress?” It is: what kind of stress was measured, was the outcome physiological or psychological, what device was used, and did the result actually outperform a sham or control?

HealthyLine is a wellness technology company that develops patent-backed, multi-therapy mat systems combining PEMF with technologies such as far-infrared heat, heated natural gemstones, and selected red/photon light features. This article looks specifically at what research has investigated about PEMF, stress responses, relaxation, and related measures such as autonomic activity, perceived stress, and well-being. For the broader framework used to evaluate PEMF studies, see PEMF Research and Evidence: What Does the Science Show?.

What the human evidence shows at a glance

The key pattern is that physiological relaxation and psychological relaxation are not interchangeable. A measurable shift in autonomic tone may occur without a matching change in how someone reports feeling.

What does “stress and relaxation” mean in these studies?

·        Autonomic regulation: changes in heart-rate variability or related measures of sympathetic and parasympathetic activity.

·        Cardiovascular relaxation: changes in resting blood pressure or vascular measures.

·        Hormonal stress: biomarkers such as cortisol.

·        Perceived stress: how stressed or calm someone reports feeling.

·        Anxiety-related symptoms: changes on validated anxiety or mood questionnaires.

·        Recovery from acute stress: how quickly the body moves back toward baseline after exercise or another physical stressor.

A study can be positive in one category and neutral in another. That is not a contradiction; it means the study measured different layers of the stress response.

What individual human studies found

Grote et al. (2007): autonomic recovery improved after physical stress, but people did not feel different

This randomized, double-blind, sham-controlled crossover study included 32 healthy men who completed standardized physical stress tests before receiving a 20-minute PEMF session.

Researchers tracked heart-rate variability and found that the active exposure accelerated recovery of certain HRV components compared with sham. That suggests the autonomic nervous system moved back toward baseline more quickly.

But the participants did not report a corresponding improvement in general well-being. This is one of the clearest examples of the gap between physiological relaxation and consciously feeling more relaxed.

Source: PubMed record

Rikk et al. (2013): whole-body low-intensity PEMF and resting blood pressure

A randomized clinical trial followed 54 middle-aged and older adults for 12 weeks using a whole-body PEMF mattress.

The system delivered an extremely low-frequency pulsed signal at a reported intensity of 100 microtesla, with 15-minute sessions five days per week.

The active group showed statistically significant reductions in resting systolic blood pressure and pulse pressure. Diastolic pressure and arterial stiffness did not change significantly.

This study is relevant to consumer-style whole-body systems because the delivery format and low-intensity exposure are similar. Still, lower blood pressure is a cardiovascular outcome, not direct proof that someone feels calmer or less psychologically stressed.

Source: ResearchGate record

Viti et al. (2023): parasympathetic HRV changed after high-intensity clinical PEMF

A randomized, sham-controlled pilot study in adults with chronic musculoskeletal pain used a PAPIMI high-intensity clinical device and measured short-term changes in HRV.

The active group showed increases in RMSSD and high-frequency HRV, both commonly used as markers of parasympathetic activity.

The 2023 randomized sham-controlled study measured acute HRV changes but did not test whether those changes correlated with pain relief. A separate 2025 Viti pilot reported reduced pain, increased RMSSD and high-frequency HRV, and no significant correlation between the pain and HRV changes.

The device itself is not comparable to a consumer mat. It uses very high-intensity, spark-gap induction and a localized applicator.

Source: PubMed record

Nieuwenhuijsen et al. (2017): no added benefit for chronic occupational stress or hair cortisol

A three-arm randomized trial included 96 workers on sick leave with chronic work-related stress complaints; 84 completed all measurements. The intervention combined light therapy, PEMF, and coaching.

All groups improved over time, but there was no statistically significant advantage for the active PEMF-plus-light group over sham treatment or coaching alone on distress, fatigue, or hair cortisol.

This is important negative evidence. It does not show that PEMF cannot affect acute autonomic measures, but it does argue against broad claims that PEMF reliably lowers chronic cortisol or treats occupational burnout.

Source context: Trial evaluation document

Hattapoğlu et al. (2019): anxiety and depression improved, but not more than sham

A prospective randomized, double-blind, placebo-controlled trial in 64 adults with cervical disc herniation measured anxiety and depression alongside pain and quality of life.

Both groups improved over the three-week treatment period, but there was no significant between-group difference in anxiety or depression.

Because both groups also received active physical therapy, including TENS and heat, this study does not support a distinct PEMF effect on anxiety.

Source: PubMed record

Martiny et al. (2010): transcranial PEMF improved depression; a later reanalysis examined autonomic side effects

The original randomized, double-blind, sham-controlled trial included 50 people with treatment-resistant depression and used a seven-coil transcranial PEMF helmet.

The active treatment improved depressive symptoms compared with sham, and the original trial reported few and mild treatment-emergent side effects. A 2011 reanalysis of 40 of the original participants reported more autonomic symptoms with active T-PEMF than with sham.

This matters because an antidepressant effect is not the same endpoint as relaxation; the study evaluated transcranial treatment of depression, not whether participants felt calmer.

The transcranial helmet format is also not comparable to a consumer whole-body mat.

Source context: PMC article

Marmann and Schmieke (2026): subjective sleep satisfaction and restfulness improved, while global sleep quality did not outperform sham

A remote randomized, double-blind, placebo-controlled trial evaluated a portable MagHealy pulsed-magnetic-field device in 217 adults with non-restorative sleep, difficulty initiating sleep, or frequent nighttime awakenings.

The active intervention did not significantly outperform sham on the global Pittsburgh Sleep Quality Index, but it produced small statistically significant between-group improvements in subjective sleep satisfaction and restfulness. WHO-5 well-being, MYMOP symptom burden, and daytime sleepiness improved in both groups without significant between-group differences.

The trial is useful for subjective relaxation outcomes, but it relied heavily on self-report and did not include objective autonomic measures such as HRV or polysomnography.

The corresponding author was an employee of Healy GmbH, the study sponsor, which should be considered when interpreting the findings.

Because the intervention was a portable localized device rather than a mat, the result is only partially relevant to consumer mat use.

Source: Open-access study page

Havas and Symington (2022): whole-body mat pilot showed mixed HRV responses

A small uncontrolled pilot study examined immediate HRV changes in 20 volunteers after one 36-minute session on a low-intensity whole-body PEMF mat.

The authors reported favorable HRV changes in about 72% of participants, while the remaining participants showed no change or worsened immediately after the session.

The study is relevant in form factor because it used a consumer-style whole-body mat, but the lack of a sham control and reliance on a proprietary HRV interpretation system make the findings preliminary.

Source: Medical Research Archives article

Post-COVID fatigue pilot: mood, insomnia, and fatigue improved with a high-intensity clinical device

A randomized placebo-controlled pilot study in 20 people with post-COVID fatigue syndrome reported improvements in depression, insomnia severity, and fatigue after a five-week course of PEMF.

The population was highly specific and the device was a high-intensity PAPIMI clinical system, not a consumer mat.

The study therefore adds context to the broader stress literature but should not be generalized to everyday stress or relaxation.

Source: ResearchGate record

Fibromyalgia BEMER trial: active and sham groups improved similarly

A randomized crossover study in 108 women with fibromyalgia used a whole-body BEMER system and compared active treatment with an inactive sham.

Both groups improved in pain and stiffness, but the per-protocol analysis found no meaningful difference between active and sham treatment.

This is especially important because the form factor is directly relevant to consumer PEMF mats. It shows that subjective symptom improvement can occur even when the active field does not outperform the treatment setting and expectancy effects.

Source: ResearchGate record

Where the evidence looks most promising

The clearest signal is in objective physiological measures, especially heart-rate variability and some cardiovascular markers. Several studies suggest that PEMF can influence autonomic tone, particularly during recovery from physical stress or in specific clinical populations.

That does not mean every person will feel calmer. Grote showed faster HRV recovery without a corresponding improvement in general well-being. The 2023 Viti study showed acute HRV changes after PAPIMI, while the separate 2025 Viti pilot found that pain and HRV changes did not significantly correlate.

Where the evidence is weak or inconsistent

·        Chronic psychological stress: controlled trials do not consistently show a benefit over sham or behavioral care.

·        Cortisol: the evidence reviewed here does not support a reliable cortisol-lowering effect.

·        Anxiety: results vary by population and device, and some controlled studies show no advantage over sham.

·        Subjective relaxation: self-reported improvements are highly susceptible to placebo and treatment-context effects.

·        Long-term autonomic effects: many HRV findings are acute and do not establish durable changes.

A calmer nervous system is not always the same as feeling calmer

This is the central lesson from the stress literature. HRV, blood pressure, and other physiological measures can change even when a person reports no difference in mood or well-being.

That means phrases such as “activates the parasympathetic nervous system” or “promotes relaxation” need context. A study may show a short-term autonomic shift, but that is not the same as proving a reliable psychological relaxation effect.

Can these findings be applied to consumer PEMF mats?

Some studies are more relevant than others. The whole-body mattress study on resting blood pressure and the small HRV mat pilot used low-intensity, whole-body systems that are much closer to consumer PEMF mats in form factor.

Other studies used devices that are not comparable, including high-intensity spark-gap systems and transcranial helmets.

Even when the form factor is similar, transferability is not automatic. Frequency, intensity, waveform, session duration, population, and the exact endpoint still matter.

The directly relevant whole-body evidence is also mixed: some studies report physiological changes, while the fibromyalgia BEMER trial did not show an advantage over sham.

What can responsibly be said?

·        Some human studies have found that specific PEMF protocols can influence heart-rate variability and other markers of autonomic recovery.

·        PEMF has shown physiological effects after acute physical stress even when participants did not report feeling more relaxed.

·        A whole-body low-intensity PEMF mattress study reported reductions in resting systolic and pulse pressure over 12 weeks.

·        Research on chronic psychological stress, cortisol, and anxiety is mixed and does not support broad treatment claims.

·        Results from high-intensity clinical devices or transcranial systems should not be generalized to consumer PEMF mats.

What the research does not support

·        “PEMF lowers cortisol.”

·        “PEMF mats treat chronic stress.”

·        “PEMF cures anxiety or depression.”

·        “PEMF instantly activates the vagus nerve and makes you feel relaxed.”

·        “A rise in HRV proves psychological stress has been reduced.”

·        Using a high-intensity or transcranial clinical study as proof of what a consumer mat will do.

Bottom line

PEMF and stress research is more convincing when it looks at measurable physiology than when it looks at subjective psychological stress. Heart-rate variability and some cardiovascular measures show promising responses under specific protocols, while cortisol, anxiety, and perceived relaxation are much less consistent.

The practical takeaway is to keep the outcome specific. A study showing an autonomic shift is evidence about autonomic physiology, not proof that a person will feel calmer or that a consumer mat treats stress.

Consumer mat relevance depends on how closely the study matches the device format and exposure conditions. Some whole-body studies are relevant, but the evidence remains mixed and should not be stretched into universal relaxation claims.

Studies discussed on this page

The links below jump to the section where each study is discussed. Full study names are listed here for reference.

·        Grote et al. (2007): Short-term effects of pulsed electromagnetic fields after physical exercise are dependent on autonomic tone before exposure

·        Rikk et al. (2013): Influence of pulsing electromagnetic field therapy on resting blood pressure in aging adults

·        Viti et al. (2023): Modulation of Heart Rate Variability following PAP Ion Magnetic Induction Intervention in Subjects with Chronic Musculoskeletal Pain: A Pilot Randomized Controlled Study

·        Viti et al. (2025): PAPIMI Short Effect on Pain Perception and Heart Rate Variability in Chronic Musculoskeletal Pain: A Pilot Study

·        Nieuwenhuijsen et al. (2017): Evaluation of a randomized controlled trial on the effect on return to work with coaching combined with light therapy and pulsed electromagnetic field therapy for workers with work-related chronic stress

·        Hattapoğlu et al. (2019): Efficiency of pulsed electromagnetic fields on pain, disability, anxiety, depression, and quality of life in patients with cervical disc herniation: a randomized controlled study

·        Martiny et al. (2010): Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression

·        Marmann & Schmieke (2026): Efficacy and Safety of Pulsed Magnetic Therapy in Sleep related Disorders: A Remote, Randomized, Double-Blind, Placebo-Controlled Trial

·        Havas & Symington (2022): Pulsed Electromagnetic Field Therapy (Seqex, Theta) Promotes Well-being as assessed by Heart Rate Variability: A Pilot Study

·        Post-COVID fatigue pilot: Feasibility, acceptance and effects of pulsed magnetic field therapy in patients with post-COVID-19 fatigue syndrome: A randomized controlled pilot study

·        Fibromyalgia BEMER trial: Pulsed electromagnetic field therapy in the treatment of pain and other symptoms in fibromyalgia: A randomized controlled study

Editorial note: This page summarizes published human research. It does not claim that a specific consumer PEMF mat reproduces the devices, protocols, or outcomes used in these studies.